Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 5028

1.

HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.

Momosaki S, Nakashima Y, Kojiro M, Tabor E.

J Viral Hepat. 2005 May;12(3):325-9.

PMID:
15850475
2.

Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.

Hsia CC, Scudamore CH, Di Bisceglie AM, Tabor E.

J Med Virol. 2003 May;70(1):20-6.

PMID:
12629639
3.

Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area.

Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P, Bréchot C.

Hepatology. 1993 Jan;17(1):20-9.

PMID:
8380790
4.

The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.

Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.

J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. Erratum in: J Exp Clin Cancer Res 2000 Mar;19(1):125.

PMID:
10606185
5.

HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.

Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.

J Med Virol. 2003 Dec;71(4):492-8.

PMID:
14556260
6.

Molecular mechanism of hepatocarcinogenesis.

Sheu JC.

J Gastroenterol Hepatol. 1997 Oct;12(9-10):S309-13. Review.

PMID:
9407351
7.

Genomic mutations with amino acid substitutions of circulating hepatitis B virus found in non-B, non-C patients with hepatocellular carcinoma.

Nakamoto N, Saito H, Ebinuma H, Tada S, Saito Y, Kurita S, Kitamura K, Ishii H.

Intern Med. 2003 Apr;42(4):322-30.

8.

[The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].

Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.

Korean J Hepatol. 2008 Mar;14(1):67-76. doi: 10.3350/kjhep.2008.14.1.67. Korean.

9.

Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.

Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.

Scand J Gastroenterol. 2008;43(7):849-56. doi: 10.1080/00365520801935459.

PMID:
18584524
10.

Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.

Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD.

Liver Int. 2005 Apr;25(2):236-41.

PMID:
15780044
11.

Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.

Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, Tsutsumi A, Noguchi N, Takano Y, Yashima K, Kishimoto Y, Suou T, Kawasaki H.

J Med Virol. 2000 Oct;62(2):151-8.

PMID:
11002243
12.
13.
15.

Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.

Sarin SK, Thakur V, Guptan RC, Saigal S, Malhotra V, Thyagarajan SP, Das BC.

J Gastroenterol Hepatol. 2001 Jun;16(6):666-73.

PMID:
11422620
16.

Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.

Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T.

Ann Intern Med. 2007 May 1;146(9):649-56.

PMID:
17470833
17.

Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection.

Matsui S, Ichida T, Watanabe M, Sugitani S, Suda T, Takahashi T, Asakura H.

J Gastroenterol Hepatol. 2000 Oct;15(10):1205-11.

PMID:
11106103
18.

Tight association of hepatocellular carcinoma with HBV infection in North China.

Gao JD, Shao YF, Xu Y, Ming LH, Wu ZY, Liu GT, Wang XH, Gao WH, Sun YT, Feng XL, Liang LM, Zhang YH, Sun ZT.

Hepatobiliary Pancreat Dis Int. 2005 Feb;4(1):46-9.

19.
20.

Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea.

Park BC, Han BH, Ahn SY, Lee SW, Lee DH, Lee YN, Seo JH, Kim KW.

J Viral Hepat. 1995;2(4):195-202.

PMID:
7489347

Supplemental Content

Support Center